The RCVS Disciplinary Committee has suspended a London-based veterinary surgeon from the Register for six months, having found that her falsification of clinical records amounted to serious professional misconduct.
At the two-day hearing, Dr Nicola Ersilova was charged with, and admitted to, three separate incidences of false and dishonest clinical record keeping following her treatment of a collapsed cat, whilst working at Vets Now in Thamesmead, London.
The Committee heard how Dr Ersilova had suspected that Lafite the cat, belonging to Mr Yingzhan Xiao, had been poisoned, so administered fluids and treated her with Lidocaine. A lay colleague, who was assisting with the treatment, subsequently observed Dr Ersilova standing staring at the cat, which had stopped breathing, then leaving the room to go and speak to Mr Xiao. The lay colleague's evidence confirmed to the Committee that Lafite's heart was still beating at this point, and that Dr Ersilova was then heard telling Mr Xiao that Lafite had died while being treated. The lay colleague later discovered that Dr Ersilova had listed calcium gluconate on Mr Xiao's bill and not Lidocaine and, when she questioned the entry, Dr Ersilova told her she was worried about getting into trouble if she had listed Lidocaine.
Whilst reporting these irregularities to the senior veterinary surgeon at Vets Now, the lay colleague noticed that Dr Ersilova had also written "CPR unsuccessful" in the notes, although she was certain CPR (cardiopulmonary resuscitation) had not been attempted.
During a subsequent Vets Now investigation, Dr Ersilova admitted adding this false information concerning Lidocaine, calcium gluconate and CPR, saying during interview that she was aware it was serious professional misconduct and that she was prepared to take the consequences. Vets Now reported the matter to the RCVS.
The Committee considered that all evidence before it fully supported the charges against Dr Ersilova, that her conduct was clearly dishonest, and that her actions were inexcusable, especially for someone as experienced as she was. It stated that a veterinary surgeon's duty to make only truthful and accurate records was so manifest and well known to veterinary surgeons that there could be no real excuse to make such false, misleading and dishonest entries.
The Committee highlighted the comment by Dr Ersilova that she knew she had done something wrong but did not expect her colleague to report her, as providing no explanation, or excuse, for doing something which she knew to be wrong.
A number of submissions were made to the Committee in mitigation, including that Dr Ersilova had admitted her dishonesty to both her employers and the Committee; had an otherwise unblemished record over 22 years of practice; had received no immediate financial gain by her actions; and, did not cause any animal suffering.
Accepting these submissions, the Committee nevertheless felt it needed to balance them against other factors. Dr Ersilova's decision to falsify the records was premeditated and had not been taken without an opportunity for full reflection. There were numerous entries in the RCVS Code of Professional Conduct that highlighted the importance of professional integrity and accuracy, and, given the importance which the Code attached to the duty of veterinary surgeons to be truthful and honest in all their dealings with their clients, the Committee found Dr Ersilova's conduct to be "most reprehensible".
Speaking on behalf of the Disciplinary Committee, its Vice-Chairman, Professor Sheila Crispin, said: "It is of great importance that the public should be able to retain confidence in the honesty and integrity of members of the profession. Both the public and other members of the profession must be entitled to rely on the truthfulness of what a veterinary surgeon has written in the clinical records of any animal [they have] treated.
"It is [our] decision that the sanction of suspension adequately reflects the seriousness of the [Dr Ersilova's] conduct. The sanction imposed is ... the most appropriate to inform the profession how seriously such dishonest conduct will be taken, because such conduct clearly brings the profession into disrepute and ... cannot and will not be tolerated."
The Committee then concluded that the least period of suspension that could be justified was one of six months.
The BSAVA has launched the BSAVA Manual of Canine and Feline Radiography and Radiology with a new introductory text aimed at veterinary students, nurses and new graduates.
The Association says confident radiographic interpretation presents a considerable challenge and the BSAVA Manual of Canine and Feline Radiography and Radiology provides a comprehensive review of the approach to radiological interpretation, the range of variants and the key fundamental principles and their application to common diseases.
The manual features high quality radiographic reproductions demonstrating normal anatomy and key aspects of interpretation, as well as illustrations showing patient positioning and the practical approach that is the hallmark of the BSAVA manuals.
The book contains the following contents:
An extra feature is the CD, which contains all the radiographic images from the manual, so that readers can view the many images at an enlarged size.
The manual is available from October and can be ordered from www.bsava.com.
Virbac is offering a free Rapid Romanowsky stain kit and Coplin jars to practices buying easOtic and Epi-Otic in a new promotion which runs until the end of October.
easOtic is Virbac's treatment for otitis externa. It features a 1ml airless pump for precise measurement and an award-winning bottle design to aid compliance by ensuring easy and accurate application.
Epi-Otic is Virbac's antibacterial and antifungal ear cleaner for use in routine cleaning. It is pH neutral and contains sodium docusate, which dries the ear canal after application.
Practices making a qualifying purchase of both products will receive the Stain Kit, comprising the three staining solutions and three Coplin jars, free of charge.
For further information, contact your Virbac Territory Manager.
A debate held at BEVA Congress last month ended with more than 70% of voters disagreeing with the motion: this house believes that new vet schools will benefit equine veterinary practice in the UK.
The result reflects a recent industry survey indicating that up to five times as many veterinary graduates may be seeking work in equine practice as there are jobs available.
Chris Proudman, founding head of Surrey University's new School of Veterinary Medicine and Mark Bowen, Associate Professor of Veterinary Internal Medicine at the University of Nottingham's School of Veterinary Medicine and Science, advocated that new UK vet schools are important for the advancement of the profession.
Mark Bowen said: "New UK vet schools will benefit the profession by improving the standards of veterinary education and creating what the consumer wants." He argued that new schools would help improve teaching methods and clinical training, while the resultant smaller class sizes would provide greater opportunities for hands on training. Competition would also help to drive up standards and inspire other universities to instigate much-needed changes such as focusing on quality of teaching rather than research.
Chris Proudman emphasised the flexibility of a new vet school to be progressive and innovative in both curriculum design and teaching delivery. He said: "Designing a curriculum from scratch allows novel approaches to partnership working and to the One Health agenda. New schools can deliver veterinary graduates better equipped with the skills and knowledge to be the veterinary leaders of the future."
The proposers also reasoned that if school leavers cannot find a place in a UK vet school they can now attend English language veterinary schools in universities across the EU, many of which do not have European accreditation to ensure standards of education. Therefore the increase in numbers of veterinary graduates is irresistible and the authorities can only influence the numbers trained in the UK and govern the high quality of teaching that is provided in the UK.
Alastair Welch, a partner at Donnington Grove Veterinary Group in Berkshire and Lucy Grieve, vet at Darley Pre-Training in Newmarket, staunchly countered the motion. They maintained that new vet schools would have a detrimental impact on the industry over the longer term and that their introduction demonstrated a slackening of the RCVS's management of the profession.
Alastair said: "Both anecdotal and empirical data suggest that becoming a horse vet has never been harder. The seemingly endless supply of hard-working, well-qualified school leavers determined to become equine vets provides universities with a reliable income stream for years to come but at what cost? I remain to be convinced that we will not end up educating veterinary graduates who cannot find a position in their intended career."
Lucy contended that it was irresponsible and immoral to allow individuals to commit five or six years, and tens of thousands of pounds, towards a veterinary career without them first being made aware of the limited opportunities available in very popular sectors of the profession such as equine practice.
Paul Jepson, President of BEVA, said: "With more than 70% of voters opposing the motion there is clearly a discernable level of disquiet amongst BEVA members about the current job market in equine practice and the further dilution of opportunities that increased numbers of graduates will create."
To help address the growing challenges faced by new graduates BEVA has recently introduced an Internship Awareness Programme (IAP). The scheme aims to help students and vets navigate the opportunities available as an intern and helps equine veterinary practices to find the most suitable employees for their practice.
You should be able to view the debate here: http://www.fsmevents.com/beva/congress13-session34. If not, the debate can be viewed on the BEVA website by following these instructions. Click the Webinar tab. Then click register. Then complete the £0 transaction and you will be able to access the free webinars. Select 'Free sessions' (Click the + symbol). Select 'Current Affairs: New vet schools - supply and demand?'
The Animal Health Trust has begun a pilot study to investigate a possible link between seasonal canine illness (SCI) and harvest mites, continuing an initial study on the possible cause of SCI funded by the Kennel Club.
SCI is a mystery illness which in recent years has made a number of dogs walked in woodlands suddenly become ill.
Cases of SCI are usually seen from August to November, with dogs showing clinical signs of vomiting, diarrhoea and/or lethargy within 24 to 72 hours of walking in woodland. Dog owners are advised to seek immediate veterinary advice should they see these signs in their dog following a woodland walk.
So far this year, there have been 49 cases in total reported to the AHT, from across all of its current investigation sites. A number of cases reported to the charity have shown evidence of harvest mite infestation.
Charlotte Robin, SCI Research Co-ordinator at the AHT, said: "To enable us to eliminate harvest mites as a potential cause of SCI, we are advising dog owners to treat their dogs with a fipronil spray directly before walking in woodlands."
There are currently no licenced products that will specifically prevent against harvest mites, however fipronil spray is believed to be effective in preventing other mites. The researchers believe that it is important that dog owners use the spray and not the spot-on treatment, which may not provide the same level of localised protection on vulnerable areas.
Charlotte added: "Dog owners need to be aware that using fipronil spray may not protect their dog from SCI, but it could protect them from harvest mites and other external parasites. What we are trying to do with this study is eliminate the harvest mite and other external parasites from our enquiries.
In addition to advising all dog owners walking their dogs in woodlands during autumn to use fipronil spray as an external parasite treatment, the AHT is working with the Sandringham Estate in Norfolk to offer to offer dog owners who wish to participate in the study access to the spray free of charge, if deemed appropriate by their veterinary surgeon.
As this is a prescription only medicine, the charity is issuing vouchers to dog owners which they can redeem for fipronil spray through their local vet practice, on the proviso their dog is deemed a suitable candidate by their vet.
Dog owners who meet the criteria and wish to participate in the study will be required to complete a SCI online questionnaire following their visit to the Estate, and an additional follow-up questionnaire regarding the pilot study, regardless of whether their dog was taken ill or not.
You can register to take part in the pilot study at www.aht.org.uk/scipilotstudy
Image courtesy: Luc Viatour / www.Lucnix.be
Novartis Animal Health has assumed marketing responsibilities for the joint health supplement Dasuquin in the United Kingdom and Ireland.
Dasuquin is a veterinary formulation developed to deliver advanced cartilage support in dogs. It contains a combination of glucosamine hydrochloride, chondroitin sulphate, avocado/soybean unsaponifiables (ASU), and tea polyphenols. Novartis says these compounds work synergistically to protect the cartilage, thereby playing an important role in supporting and maintaining joint health.
Novartis highlights a 2007 study which, according to the company, demonstrates that the combination of ASU, chondroitin sulphate, and glucosamine hydrochloride delivers incremental benefits compared to the combination of chondroitin sulphate and glucosamine hydrochloride alone.1
Dasuquin is available in flavoured chewable tablets in 80-count containers. Dasuquin is available in two strengths: small-to-medium dogs weighing between 5 and 25 kg and for large dogs weighing over 25 to 50 kg.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "This is a fitting addition to our overall orthopaedic health offering for vets and pet owners. Dasuquin brings vets and dog owners advanced joint health support with the next generation of the popular Cosequin family."
Dasuquin is available from Novartis Animal Health in the United Kingdom and Ireland from licensed veterinary wholesalers. For more information on Dasuquin, contact your Novartis Animal Health Territory Manager
Reference:
Bimeda has announced the launch of Butagran Equi (phenylbutazone), to join its range of analgesics and anti-inflammatories.
Bimeda says that Butagran Equi provides rapid onset of activity with the added convenience for horse owners or professionals of being presented as an easy-to-administer sweetened powder.
Indications include musculo-skeletal conditions that require relief from pain and a reduction in the associated inflammation, including lameness associated with osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.
Head of Bimeda technical services Padraig Hyland MVB said: "Butagran Equi is particularly suited where continued mobility is considered desirable. It is also of value in limiting post-surgical inflammation, myositis and other soft tissue inflammation and can be used as an anti-pyretic where this is considered advisable, such as in viral respiratory infections. And being a sweetened powder it's quite straightforward for horse owners to administer and dose as prescribed."
He added: "Butagran Equi follows the launch of a number of new products and is proof our desire to provide a comprehensive and relevant equine portfolio backed up with first class technical support."
The RCVS has launched a mobile version of the Code of Professional Conduct for veterinary surgeons and veterinary nurses: an app for Android devices and a web app for Apple users.
Once installed, the app provides smartphone and tablet users with a mobile-friendly version of the Code and all 27 chapters of supporting guidance in their pockets, even when there is no network connection. Whenever the Code is updated, the latest version will be available to download the next time the device is online.
Head of Communications, Lizzie Lockett, said: "Our new app provides easy access to the Code, so busy veterinary surgeons and veterinary nurses can now keep our guidance to hand, even when out and about. It's never been easier to ensure that you're always working to the Code's principles of veterinary practice and professional responsibilities."
The app also offers a keyword search of the whole Code and supporting guidance, links to other sources of information and contact details for further advice over the phone or email.
To install the RCVS Code of Professional Conduct app on your android device, visit Google Play and search for 'RCVS code'. To install it on an Apple device, visit the RCVS Code web pages in the device's internet browser, click on the app link in the Code tool box on the right hand side, and follow the instructions.
Alternatively, a copy of the full Code and all supporting guidance can now be downloaded in PDF format from the RCVS website, date-stamped so that you know when it was last amended.
Visit www.rcvs.org.uk/code or www.rcvs.org.uk/vncode and see the 'Code tools' box for both the PDF and the web app.
The College says it would very much like feedback about the app, or suggestions for future apps - email Christine James in the Communications Department, on christinej@rcvs.org.uk.
Virbac, in conjunction with the European Veterinary Dental Society, has launched an online dental charting system called the Electronic Veterinary Dental Scoring System for use by small animal practitioners.
The system aims to enhance the performance of clinicians conducting dentistry and to encourage a thorough review of the oral cavity during the annual check up.
The system allows you to record clinical findings on online dental charts and build up a history for each patient. There are also a series of tutorials to help in making clinical decisions. Virbac says the e-VDS system also encourages owner compliance with treatment regimes as it provides downloadable materials, including an assessment of their pet and follow up reports.
Dr Gottfried Morgenegg-Wegmüller, who was the EVDS project lead on this development, said: "It was always my vision to give veterinary dentistry the importance it deserves. The most effective way to achieve this is by targeting the general practitioner and encouraging them to have a closer look at the oral cavity of their patients."
Victoria Hudson, Product Manager for dental products at Virbac, said: "Poor dental health is a major issue for dogs and cats yet many practices are yet to capitalise on the opportunity to help increase the animal's welfare and health. Many owners are simply unaware of the importance of caring for their pet's teeth.
"The new e-VDS system is a great leap forward in dental care, offering not just electronic charting but a raft of additional support materials, all of which are practical and easy to use. We hope many practices will be keen to try it - and will soon be reaping the benefit!"
e-VDS is available free of charge on http://www.my-virbac.co.uk/, Virbac's practice support portal. Practices can also contact their territory manager for more details.
Petplan has been awarded an Insurance Times Tech Award for its social media campaign entitled "Like & Donate", which was devised to support two animal charities, the Dogs Trust and Cats Protection.
As part of the campaign, pet lovers are being encouraged to donate a food pouch to either charity by "liking" the Petplan Facebook page; with one "like" equalling one pouch of food for either the cat or dog charity.
The Facebook app also allows Petplan's Facebook fans to track the progress of donations and encourage friends to visit the page and support their chosen charity. The initiative has resulted in over 48,000 food pouches being donated to the charities with the Cats Protection receiving over 29,000 "likes" and the Dogs Trust gaining 19,500.
Petplan's Head of Marketing, Isabella von Mesterhazy said: "We are delighted our Like & Donate campaign has been awarded Best Use of Social Media. At Petplan we work with over 1,700 animal charities and our Like & Donate campaign has further helped to support the fantastic work of both the Dogs Trust and Cats Protection in rehoming dogs and cats across the UK."
To take part in Petplan's "Like & Donate" programme visit www.Facebook.co.uk/Petplan.
Cats Protection is calling for an urgent shift in pet owners' thinking in order to control the UK's cat population, after being inundated with thousands of unwanted kittens again this summer.
The charity is urging owners to neuter their cats at four months of age - two months earlier than the traditional six months - because this is when cats reach sexual maturity.
The call follows a recent survey carried out by the charity which found that just 4% of people neutered their cat at or before the recommended four months.
Each year, Cats Protection takes in thousands of unwanted or abandoned kittens which are the result of unplanned breeding so the charity is keen to make cat owners aware of the need to neuter.
Jane Clements, Cats Protection's Neutering Manager said: "Getting the neutering message across is proving to be a very tough hurdle for cat welfare because our research shows the vast majority of people are still not neutering their cats early enough to avoid unwanted litters of kittens.
"Without neutering, the UK's cat population quickly gets out of control and each summer we are overwhelmed with kittens in need of homes so it is vital people ensure their cats are neutered at the correct age to prevent unwanted litters."
While the lack of early neutering was a problem across Britain, the survey found the ITV Yorkshire and ITV Central areas are the least likely to neuter at the recommended age, both with just 1% of cats neutered at or before four months.
Cats Protection is planning to open a new homing centre later this year in Gildersome, Leeds, Yorkshire, and it is hoped its presence there will raise awareness of the need for better cat welfare and early neutering. The centre will find homes for around 500 cats each year, increasing the charity's work in the region by up to 68 per cent. Information about the new centre can be found by visiting www.cats.org.uk/support-us/future-for-cats/gildersome-homing-centre.
The charity is also embarking on a large scale neutering campaign in North Birmingham, which it hopes will help to raise awareness of the issues in the area.
Cats Protection runs a national register of veterinary practices that carry out neutering at four months of age. To register your practice, please visit the website at www.cats.org.uk/early-neutering
Dechra Veterinary Products has launched Vitamin K1 tablets for dogs, which help reverse the effects of exposure to anticoagulant rodenticides.
The launch of the NFA-VPS licensed 50mg tablets means that veterinary professionals can have a ready supply of Vitamin K when treating animals which have been exposed or may have been exposed to serious poisoning. Previously, the tablets where only available as a special import certificate product following Dechra's acquisition of Eurovet.
Dechra Veterinary Products Brand Manager, Carol Morgan, said: "Vitamin K1 is an absolutely key therapy in the treatment of potential and accidental exposures to anticoagulant poisoning in animals, mainly in pet dogs. It helps to assist with blood clotting, and the treatment protocol advises continued oral therapy following an initial injectable preparation of Vitamin K.
"The Veterinary Poisons Information Service has received more than 6,000 calls so far this year to its helpline regarding suspected or confirmed poisoning of all types of animals, whether accidental or deliberate exposure.
"We had been able to offer the Vitamin K1 injection and tablets via a SIC, when previously sometimes only preparations for human use were available. Therefore, we are delighted to now launch a licensed tablet which will ensure a ready supply and speed of therapy for animals affected by anticoagulant rodenticides."
Carol added: "Anticoagulant poisoning queries are already the second most common type received by the Veterinary Poisons Information Service, and with the launch of these tablets, veterinary professions will be able to have a ready supply of vitamin K to hand. We would recommend that all practices consider stocking this product."
Vitamin K1 50mg tablets, for the treatment of anticoagulant poisoning following parenteral treatment, are available in boxes of 14 tablets, in blister packs of seven tablets.
For more information, please visit www.dechra.co.uk
The RCVS is now accepting disclosures from veterinary surgeons about any criminal cautions, convictions or adverse findings they may have against them, as part of a voluntary period before the requirement to disclose commences in 2014.
The requirement that veterinary surgeons notify the College about criminal cautions, convictions or adverse findings on registration, and on an annual basis as part of their registration renewal each March, was introduced as part of the Code of Professional Conduct in 2012 (section 5.3, see Notes to Editors). However, the College has allowed a bedding-in period for the Code before enforcing the requirement.
From 2014, new registrants will have to disclose any criminal cautions, convictions or adverse findings that may affect registration (for example, those from university fitness to practise procedures).
Veterinary surgeons already on the Register (including overseas and non-practising categories, as well as UK-practising) will only be required to disclose criminal cautions, convictions or adverse findings that have occurred since April 2006. Fixed-penalty motoring offences are excluded.
The veterinary profession has fallen under the Notifiable Occupations Scheme since April 2006, which means that serious convictions are already passed to the College from the police.
If a veterinary surgeon declares a criminal conviction, this will be initially considered by the Registrar, and, if necessary, referred to the Preliminary Investigation Committee. In some cases, the matter will be referred on to the Disciplinary Committee to decide if the nature of the caution or conviction affects the veterinary surgeon's fitness to practise - in which case the usual sanctions of removal or suspension from the Register could apply.
Eleanor Ferguson, Head of Professional Conduct said: "We hope, through this new requirement, to increase the public's confidence in the veterinary profession, and to safeguard animal health and welfare. The move brings the veterinary profession into line with many others - including registered veterinary nurses, who have made such a disclosure since their Register was introduced, in 2007."
The RCVS has launched a dedicated advice line to assist affected veterinary surgeons, on 07818 113 056, open Monday to Friday, 11am-4pm.
Callers will speak to one of three RCVS solicitors who can advise on the process and the possible outcomes of disclosure. Alternatively, veterinary surgeons can contact disclosure@rcvs.org.uk.
Detailed information regarding the requirement, including examples of the kinds of convictions that may be referred to the Preliminary Investigation Committee, and a disclosure form, can be found on www.rcvs.org.uk/convictions.
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
The RCVS Disciplinary Committee has agreed to adjourn multiple charges against an Essex-based veterinary surgeon who qualified in 1969, following his undertakings firstly to request removal from the RCVS Register and secondly never apply to be restored to it.
At the hearing, which had originally been listed for seven days, Geoffrey Raymond Oliver, 68, was charged with serious professional misconduct over allegations of his inadequate treatment of two dogs and a cat (belonging to three different clients) between 2010 and 2012; inadequate record keeping; failures to deal honestly or properly with his clients; and, failure to heed advice from the RCVS Preliminary Investigation Committee about the importance of proper communication between veterinary surgeons and their clients.
However, before the Committee heard evidence on any aspect of these charges, Mr Oliver lodged his application for adjournment. The Committee therefore made no findings on the charges, and emphasised they had neither been proved against, nor admitted by, him.
The Committee noted that there had been no adverse findings against Mr Oliver during his professional career, that his practice was now closed and that he had no intention of returning to practise in the future. Should he subsequently apply to be restored to the Register, the Committee would resume its consideration of the charges, along with his breach of the undertaking.
The Committee was advised that none of the complainants in the case - which could have incurred considerable time and costs - dissented from the proposed course of action.
Speaking on behalf of the Disciplinary Committee, its Chairman, Professor Peter Lees, said: "The Committee has concluded that no useful purpose would be served were it to insist on a full hearing [and it] would be a disproportionate waste of...resources [to do so]. The Committee is satisfied that [granting the adjournment application] protects the welfare of animals and...is in the public interest."
The Committee then accepted Mr Oliver's undertakings, including the removal of his name from the Register with immediate effect.
Professor Lees added: "So that he is in no doubt about the matter, the Committee reminds [Mr Oliver] that, when referring clients of his former practice elsewhere, he should be careful to avoid giving them any advice about the diagnosis or treatment of their animals."
Merial, the manufacturer of FRONTLINE Combo, FRONTLINE Spot On and Merilym3 has announced that Bill Oddie will front its autumn 'Be Tick Aware' PR campaign to highlight the importance of protecting pets from ticks.
The campaign will run throughout September and into October to drive awareness via print, broadcast and digital media.
Merial says the campaign has been designed to raise awareness of ticks and tick-borne diseases amongst vets, pharmacists and SQPs and in turn to educate pet owners on the importance of regularly treating their pets for ticks.
The company is also continuing its partnership with BADA-UK, the tick-borne disease charity whose own demonstration dog, Shaun, recently suffered with Borreliosis (Lyme disease).
BADA-UK founder and Chair, Wendy Fox, said: "The infection highlights the very real risk of contracting tick borne diseases, even for the most well-cared for dogs and tick-aware owners. We find a lot of owners genuinely believe their dogs cannot get ticks because they keep their animals clean and well groomed. This sort of misconception is notable even at canine events where you might expect to encounter the best informed dog owners, but the sad fact is many people still do not take the risk of tick-borne diseases seriously enough."
Roddy Webster Head of Pets UK from Merial said: "It is a pleasure to work with Bill Oddie, a fellow animal lover and expert, to highlight the risk of ticks this autumn. Ticks and tick-borne diseases are an increasing threat, and the risk in the UK is rising. Ticks are considered to be second only to mosquitoes as vectors of infectious diseases around the world. Disease-transmitting ticks can be found anywhere - gardens, forests, parks and even beaches. This campaign is designed to encourage vets, pharmacists and SQPs to educate their clients and customers about ticks, the dangers of tick-borne disease and the importance of regular tick prevention. We're extremely excited about this campaign and we're looking forward to seeing the positive effects."
Virbac has announced that Canine Prostate Awareness Month, its initiative to highlight the prevalence of Benign Prostatic Hyperplasia (BPH), will be running again in November, and is urging practices to join in.
The initiative is timed to coincide with Movember, the fundraising initiative for male prostate disease and testicular cancer. Virbac says it hopes CPAM will remind owners that men are not the only ones to suffer from prostate disorders. Indeed, more than 80% of entire male dogs over the age of five are thought to suffer from BPH1.
As part of CPAM, Virbac is providing participating practices with promotional materials including owner educational and display materials, a template press release for local media, and free branded slip leads to pass on to owners who have had their dog checked.
Chris Geddes MRCVS, Senior Product Manager, said: "CPAM is a well-supported initiative and, running it at a time when the media spotlight is already on the dangers of prostate cancer in men, means we can spread the message that owners should also be monitoring older dogs for signs of prostate disease."
Virbac has introduced Odelis CPSE, the first ELISA test to screen for, diagnose and monitor BPH. It is available from three UK diagnostic laboratories. According to the company it is a cost-effective, precise and reliable alternative to rectal palpation. It also offers Ypozane, a tablet treatment for BPH, which takes effect within a week and lasts for six months.
Chris added: "The problem with BPH is that the majority of dogs suffer in silence. It is a painful condition that goes unnoticed until it reaches an advanced stage, where the owner notices blood in the urine or painful urination.
"We're providing practices with all the materials they need to promote the campaign in their locality and hope that those getting involved will find it effective in terms of bringing clients into the practice for advice on BPH. We've also organised coverage in national dog magazines to drive clients to practices."
Practices that diagnose a dog with BPH during CPAM are asked to contact Virbac with details as it plans to collate a series of case studies from the initiative. Love2Shop vouchers to the value of £50 will be provided for the five most pertinent case studies submitted by the end of 2013.
For further information on CPAM, email cpam@virbac.co.uk, contact your Virbac Territory Manager or call the company direct on 01359 243243.
Reference
Freelance Surgical Ltd has announced that it is now the sole UK distributor for IMEX Veterinary, Inc. external fixation products.
In fact, Freelance Surgical has been a supplier of IMEX products for over a year, but says that most customers had been buying from Animalcare, which has now ceased selling the products.
The company says external fixation is an effective method of orthopaedic fracture repair which has gained popularity in recent years. An external skeletal fixator (ESF) can be used as a primary fracture fixation device or to enhance stability provided by another primary fixation product. In some cases and when used correctly, the company says they can have a number of advantages over other fracture repair techniques.
The IMEX Veterinary, Inc. product portfolio includes an array of external skeletal fixation components, intramedullary pins, K-wires, orthopaedic wire and other related veterinary products. The modular ESF system is comprised of linear, hybrid and circular fixation with linear components common to all three and instrumentation interchangeable between the hybrid and circular external fixation systems.
James Towler, Veterinary Director at Freelance Surgical Ltd has received professional training with IMEX Veterinary, Inc. to ensure the UK market has access to up-to-date product and ordering information.
For more information contact Freelance Surgical Ltd on 0845 050 4147.
The Goddard Growlers are putting the final touches to their training ahead of the Vet Charity Challenge event which takes place at Pershore College in Worcestershire on 28 September.
The team comprises Stone Lion Head Vet Roger Bralow; Practice Manager for North West London, Adrian Hayter; Philippa Davis, Regional Manager for NE London and Lisa Cooper, VN and Hospital Manager for Wanstead Hospital.
Philippa Davis said: "Our training regime is going well despite the injuries we've sustained making us consider that we might be 'too old' for this malarkey. I've certainly had to stop saying 'I don't do' running as I've found that I'm enjoying it and will continue to do it after the challenge. We make a great team and while the events will be very tough, we'll have some laughs along the way.
We certainly have a will to win and our fellow teams will find us highly competitive and growling at them at every opportunity! Seriously though, we're all really looking forward to it and watching the long range weather forecast with unusual interest! We're also delighted to be helping the fantastic causes which the Vet Charity Challenge is fundraising for this year. Our colleagues across the Goddard Group are giving us great support and we have already raised more than £600. Bring it on!"
The Growlers' progress can be followed by 'liking' their facebook page, 'Goddard Growlers', which also provides links for anyone wanting to support them with sponsorship. Alternatively, donations can be made at http://uk.virginmoneygiving.com/team/goddardgrowlers
The University of Bristol's School of Veterinary Sciences at Langford has opened a £2 million state-of-the-art dairy farm.
Wyndhurst Farm's dairy unit has undergone a major rebuild in order to provide a world-class practical teaching environment for around 600 veterinary students, as well as a facility that can be used to support research and the continual professional development of veterinary surgeons, farmers and others involved in the dairy industry locally, nationally and internationally. Professor Jo Price, Head of the School of Veterinary Sciences, said: "This is an exciting time for the Vet School. The new dairy unit will enable our undergraduate and postgraduate students to be taught in a world-class facility. It will provide the best standards of animal welfare for our dairy herd and will support our research on the prevention and treatment of diseases of farm animals."The farm, which is approximately 250 acres, includes numerous features to ensure high welfare standards. The dairy herd will be housed in deep sand bedded cubicles, with parts of the floors covered in soft rubber to protect the cows' feet and when housed cows will be fed a total mixed ration using grass, maize and whole crop wheat silages grown on the farm.Since the new facility has been built the farm's herd of Pedigree Holstein cows have increased in number from 110 to 180 cows and will soon reach 200, with each cow giving over 9,000 litres of milk per year. The farm also has a newly established breeding flock of 100 New Zealand Romney ewes. Since 2010 it has been managed by Velcourt Farm Management.
Bayer Animal Health, maker of Advantage, has produced a new animation to educate pet owners about fleas.
The three minute animation, which is available on YouTube (below), is also available from Bayer for practices to play in the waiting room.
For a copy of the animation, contact your local Bayer Animal Health Territory Manager. More information is also available at http://www.advantagespoton.co.uk/.
Norbrook Laboratories has launched Noroseal, a new teat sealant containing a unique anti-infective ingredient.
The company says that Noroseal, a 2.6g intramammary suspension, is the only teat sealant in the market-place in Europe to contain a PVP-Iodine excipient.
Dr Barry McInerney MVB, MRCVS, PhD, Norbrook GB Veterinary Advisor said: "Noroseal, with its unique formulation, offers vets a proven barrier against intramammary infections during the dry period.
"New bacterial infections occur most often during the first three weeks of drying off because the cow's natural keratin plug is not completely formed. Indeed, approximately 50% of teat canals are still open for up to seven days after drying off. Noroseal Teat Sealant will mimic the cow's keratin teat barrier offering immediate protection against infection. Additionally, the anti-infective ingredient, PVP-Iodine, complements the effectiveness of the teat-sealant components in the teat canal barrier."
Norbrook says that the estimated annual cost of mastitis to the UK dairy industry is in excess of £168M with a single case of clinical mastitis costing farmers approximately £178.00 per cow.
Dr McInerney added: "Clinical mastitis is a costly business but one that can be avoided if timely action is taken. There are various treatments available for dealing with mastitis but studies have shown that the risk of clinical mastitis may be reduced by up to 50% by using a combination of teat sealant and dry cow intramammary therapy. Noroseal is therefore an ideal combination with Norbrook's dry cow therapies such as Noroclox DC, Bovaclox DC Xtra and Bovaclox DC."
Noroseal is available in packs of 24 or buckets of 120 units. A range of promotional material is also available to veterinary practices via the Norbrook Sales Team.
The Webinar Vet has launched a new Scholarship membership which offers final year vet students unlimited access to its CPD webinars.
Webinar Vet founder, Anthony Chadwick MRCVS said: "We wanted to put something back into the profession and this seemed the ideal way to do so.
"All final year UK and international students are eligible to sign up, free of charge, for our small animal Platinum Membership - there are no hidden catches! This will give access to our weekly clinical webinars, practice management and nurse webinars as well as the huge archive of previous webinars to watch at their leisure or when they need information on a specific topic.
"Following a tremendous response at SPVS final year student conference over 100 have signed up so far. As well as the webinars students also receive regular blogs, e-newsletters and Platinum discounted rates on all additional specialist webinars. We also welcome international vets too as part of our mission of making high quality affordable CPD accessible to vets worldwide - and you can't get more affordable than free!"
For free membership go to http://thewebinarvet.com/studentscholarship or contact the Webinar Vet on 01513 240580.
Bayer Animal Health has launched a free mobile app for pet owners, offering a bespoke parasite treatment reminder service, to help them follow their parasite protection plan prescribed by their vet.
The app was launched following a survey that found that 65% of pet owners do not regularly use parasite treatment products and are not certain that their pet is adequately protected against fleas, ticks, lice, mites and intestinal worms1. In addition, 83% of owners do not realise full protection against parasites requires a combination of two or more treatment products, and 45% are not confident that they have the job under control2.
The app allows owners to develop an on-going parasite protection plan in line with their veterinary prescription and receive automated reminders on treatment dates. In addition, the app allows users to set reminders for vaccination boosters, other vet appointments, and entering special dates like their pet's birthday or grooming appointments.
Once downloaded, users can create a pet profile to keep track of all their information in one place, including breed details, microchip number, weight, and date of birth of their dogs, cats, rabbits and ferrets. A 'learn' section of the app is also available to provide owners with the general information about parasites and the risk they pose to pets and family members.
The Jungle for Pets app is initially available to download for iPhones and iPads, by searching 'Jungle for Pets' in the Apple App store or clicking here.
VetSurgeon downloaded the app to try it out. A very polished app which has the potential to be extremely useful for those of us that can't remember our own names, let alone when the dog is due to be wormed. Three problems we found, which will doubtless be ironed out in future updates: Firstly, whilst the app works on an iPad, it's sized for and looks better on an iPhone. Secondly, it demanded a photo of the dog for registration. Whilst that's easy enough to do with an iPhone, the app then froze when we tried. Perhaps it should be optional. Finally, whilst the app very usefully allows for reminders of non-Bayer products, it doesn't appear to allow the user to type in the name of the product, forcing it to be listed as 'other'. We suspect that anyone who can't remember treatment dates (probably most of us) also won't be able to remember what 'other' was, especially if there are more than one or two 'other' products.
References
BCF Technology has launched a competition to win a top of the range digital radiography system from its Cuattro range for 6 months.
To enter the competition, you need to record a short video (up to 2 minutes) explaining how the DR system would transform your imaging function. BCF is asking entrants to be as creative as possible as the voting will be open to the public. The company will pick a shortlist of finalists and then invite the public to vote for a winner on its Facebook page and website.
The competition is open to both small animal and equine vets, for the following systems:
Sarah O'Grady from BCF said: "Having a Cuattro DR system could make a huge difference to either a small animal or an equine practice. For a small animal vet practice that doesn't currently have a DR system, they will love the difference it makes to X-ray studies. Diagnostic images are produced in seconds and re-takes are almost non-existent. A Wireless Slate 3+ can greatly improve the ease of in-stable operations and procedures. With the removal of wires, these procedures run much smoother. You will also be surprised by the improvement in image quality."
The closing date for the competition is 30th November 2013.
To enter your video:
The winner will be required to arrange insurance for the system during the time they have the system. Full terms and conditions can be found on the BCF website.
To find out more visit the BCF website or Facebook page or call +44 (0)1506 460 023.